Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.05 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:30 PM 04/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Claire Poll B.A., B Juris, LLB, ASIA

Executive Director and Member of Audit Committee, Verona Pharma plc
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 4 different industries.

See Board Relationships
--94,787 GBP
As of Fiscal Year 2014

Background*

Ms. Claire Louise Poll, Bjuris, BA, LLB, ASIA, served as a Director of Corporate Development of Inniarsat. At Inniarsat, Ms. Poll was responsible for group strategy, mergers and acquisitions and advising the Inmarsat board on investing in new satellite technology. She has 12 years experience as a corporate executive for start-up and mature technology companies internationally. Prior to Inmarsat, she held corporate development and legal roles in the telecommunications, ...

Read Full Background

Corporate Headquarters*

Alpha House
London, Greater London SE1 1LB

United Kingdom

Phone: 44 20 7863 3300
Fax: 44 20 7863 3314

Board Members Memberships*

Director
Non-Executive Director
Former Director
2005-2006
Former Executive Director
2006-2007
Former Director
2006-Present
Executive Director and Member of Audit Committee

Education*

Associate's Degree
Financial Services Institute of Australasia
LLB
The University of Western Australia
Bachelor's Degree
The University of Western Australia
BA
The University of Western Australia

Other Affiliations*

Annual Compensation*

Salary70,000 GBP
Bonus7,500 GBP
Total Annual Compensation77,500 GBP

Stock Options*

Exercisable Options2,833,334
Unexercisable Options2,916,666
Total Number of Options5,750,000

Total Compensation*

Total Annual Cash Compensation77,500 GBP
Total Short Term Compensation77,500 GBP
Total Calculated Compensation94,787 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNAPF:US $0.05 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERONA PHARMA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.